Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

admin · 发表于昨天 19:57

马上注册，阅读更多内容，享用更多功能！

您需要登录才可以下载或查看，没有账号？立即注册

×

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.
Medscape Medical News

账号		自动登录	找回密码
密码			立即注册